Stereospecific synthesis of functionalized ether phospholipids

Journal of Organic Chemistry

Volumn 64, Issue 26, 1999, Pages 9337-9347

  Kazi, Abul B ^a,b   Shidmand, Sean ^a   Hajdu, Joseph ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b MISSISSIPPI VALLEY STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHER PHOSPHOLIPID;

ARTICLE; CATALYSIS; CHIRALITY; COMPLEX FORMATION; DRUG SYNTHESIS; HYDROLYSIS; PHOSPHORYLATION; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOSPECIFICITY;

EID: 0033601204     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo990739v     Document Type: Article

References (43)

1. (a) Hanahan, D. J. Annu. Rev. Biochem. 1986, 55, 483.
2. (b) Snyder, F. Med. Res. Rev. 1985, 5, 107.
3. Blank, M. L.; Snyder, F.; Byers, L. W.; Brooks, B.; Muirhead, E. E. Biochem. Biophys. Res. Commun. 1979, 90, 1194.
4. (a) Berdel, W. E.; Andreesen, R.; Munder, P. G. In Phospholipid and Cellular Regulation; Kuo, F. J., Ed.; CRC Press: Boca Raton, FL, 1985; Vol. 2, pp 42-77.
5. (b)Berdel, W. E.; Munder, P. Platelet-Activating Factor and Related Lipid Mediators; Snyder, F., Ed.; Plenum Press: New York, 1987, pp 449-467.
6. (a) Munder, P. G.; Weltzien, H. O.; Modolell, M. Immunopathology, VIIth Int. Symposium, Bad Schachen; Niescher, P. A., Ed.; Schwabe: Basel, 1976, pp 411-424.
7. (b) O'Flaherty, J. T.; Wykle, R. L. Clin. Rev. Allergy 1983, 1, 353.
8. Vogler, W. R.; Whigham, E., Bennett, W.; Olsen, A. C. Exp. Hematol. (Charlottesville, Va) 1985, 13, 629.
9. (a) Helfman, D. M.; Barnes, K. C.; Kinkade, J. M., Jr.; Vogler, W. R.; Shoji, M.; Kuo, J. F. Cancer Res. 1983, 43, 2955.
10. (b) Zheng, B.; Ioshi, K.; Shoji, M.; Eibl, H.; Berdel, W. E.; Hajdu, J.; Vogler, W. R.; Kuo, J. F. Cancer Res. 1990, 50, 3025.
11. Kiss, Z.; Deli, E.; Vogler, W. R.; Kuo, J. F. Biochem. Biophys. Res. Commun. 1987, 142, 661.
12. (a) Snyder, F. Biochem. J. 1995, 305, 689.
13. (b) Snyder, F.; Lee, T.-C.; Blank, M. L. Prog. Lipid Res. 1992, 37, 65.
14. Kleuser, B.; Meister, A.; Sternfeld, L.; Gercken, G. Chem. Phys. Lipids 1996, 79, 29.
15. Brachwitz, H.; Langen, P.; Dube, G.; Schildt, J.; Paltauf, F.; Hermetter, A. Chem. Phys. Lipids 1990, 54, 89.
16. Bodine, P. V.; Litwack, G. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 1462.
17. Bodine, P. V.; Litwack, G. J. Biol. Chem. 1988, 263, 1462.
18. Bodine, P. V.; Litwack, G. Receptor 1990, 1, 83.
19. (a) Bodine, P. V.; Litwack, G. Mol. Cell. Endocrinol. 1990, 74, C77.
20. (b) Schulman, G.; Bodine, P. V.; Litwack, G. Biochemistry 1992, 31, 1734.
21. Bodine P. V.; Litwack, G. J. Biol. Chem. 1990, 265, 9544.
22. Malone, B.; Lee, T.-C.; Snyder, F. J. Biol. Chem. 1985, 260, 1531.
23. Kini, G. D.; Beadle, J. R.; Aldern, K. A.; Hostetler, K. Y. Presented at the 211th National Meeting of the American Chemical Society, New Orleans, LA, March 24-28, 1996; Abstr. MEDI 172.
24. (a) Guivisdalsky, P. N.; Bittman, R. Tetrahedron Lett. 1988, 29, 4393.
25. (b) The availability of this compound in high enantiomeric excess (>99%) makes it preferable to other glycidol derivatives for the stereospecific synthesis of phospholipids.
26. Dale, J. A.; Dull, D. L.; Mosher, H. S. J. Org. Chem. 1969, 34, 3543.
27. Kazi, A. B.; Hajdu, J. Tetrahedron Lett. 1992, 33, 2291.
28. In some cases, the addition of activated molecular sieves seemed to be helpful in removing traces of moisture from the reaction mixture, thereby increasing the reactivity of the anionic nucleophile (see the Experimental Section).
29. (a) Bhatia, S. K.; Hajdu, J. Lipids 1991, 26, 1424.
30. (b) Bhatia, S. K.; Hajdu, J. Tetrahedron Lett. 1988, 29, 31.
31. The N-triphenylmethyl derivatives of serine methyl ester and threonine methyl ester were prepared by the method described in ref 22a; they were obtained in 91 and 89% yields, respectively.
32. Jung, M. J.; Shaw, T. J. J. Am. Chem. Soc. 1980, 102, 6304.
33. (a) Klunder, J.; Onami, T.; Sharpléss, K. B. J. Org. Chem. 1989, 54, 1295.
34. We found that, contrary to the previous report, the pure oxazoline 11 is quite stable at room temperature (for at least several weeks). (b) Preparation of iodide 13 turned out to be necessary, because direct displacement of the tosylate with sodium iodide gave poor yields of compound 14.
35. Bodine, P. V.; Hajdu, J.; Litwack, G. Biochem. Biophys. Res. Commun. 1994, 203, 408.
36. Bodine, P. V.; Garcia, M. L.; Pascual, J.; Bastida, E.; Carganico, G.; Litwack, G. Receptor 1991, 1, 167.
37. Baker, R. R.; Chang, H. Biochim. Biophys. Acta 1996, 1302, 257.
38. Srisiri, W.; Lamparski, H. G.; O'Brien, D. F. J. Org. Chem. 1996, 61, 5911.
39. Kocienski, P. Protecting Groups; Verlag: New York, 1994, pp 192-195.
40. Carpino, L. A. Acc. Chem. Res. 1987, 20, 401.
41. (a) Letsinger, R. L.; Bach, S. A.; Eadie, J. S. Nucleic Acids Res. 1986, 14, 3487.
42. (b) Letsinger, R. L.; Groody, E. P.; Tanaka, T. J. Am. Chem. Soc. 1982, 104, 6806.
43. Dittmer, J. C.; Lester, R. L. J. Lipid Res. 1964, 4, 126.